|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.
The latest price target for Altimmune (NASDAQ: ALT) was reported by JMP Securities on June 16, 2021. The analyst firm set a price target for 53.00 expecting ALT to rise to within 12 months (a possible 231.66% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Altimmune (NASDAQ: ALT) is $15.98 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Altimmune.
There is no upcoming split for Altimmune.
Altimmune is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.